
GLP-1s have rapidly increased in popularity, Due to their seemingly remarkable ability to facilitate weight loss. These findings have led to increased interest in understanding whether GLP-1s might be useful for changing other behaviors, such as as substance use. In this episode, Dr. Joseph Schacht discusses the science behind GLP-1 medications and their potential as treatments for substance use disorders, including recent research, mechanisms, and future directions. Dr. Joseph Schacht is an Associate Professor and Co-Director of the Division of Addiction Science, Prevention, and Treatment in the Department of Psychiatry at the University of Colorado Anschutz. Learn more about his work here.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Drs. Jennifer Merrill and Mary Beth Miller - Alcohol-induced Blackouts

Dr. Eric Pedersen - Mobile Interventions for Veterans

Dr. David Epstein - Let's agree to agree

Dr. Ricky Bluthenthal - Barriers in Access to Healthcare and Harm Reduction Services
Free AI-powered recaps of The Addiction Psychologist and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.